Percutaneous transvenous balloon mitral valvotomy was performed successfully in a 57 year old man with reo fractory congestive heart failure due to calcific mitral stenosis. Cardiac surgery was not an option because of other major medical problems. Balloon mitral valvot· omy was performed using the transseptal technique. The interatrial septum was dilated with the use of an 8 mm balloon catheter to allow passage of larger balloon val· votomy catheters to the mitral anulus. The procedure resulted in a marked decrease in the diastolic transmitral Closed mitral commissurotomy is a reliable surgical technique for the treatment of patients with symptomatic mitral stenosis (1-5). This report describes the successful use of percutaneous transvenous balloon mitral valvotomy in a patient with refractory congestive heart failure due to calcific mitral stenosis.
Percutaneous transvenous balloon mitral valvotomy was performed successfully in a 57 year old man with reo fractory congestive heart failure due to calcific mitral stenosis. Cardiac surgery was not an option because of other major medical problems. Balloon mitral valvot· omy was performed using the transseptal technique. The interatrial septum was dilated with the use of an 8 mm balloon catheter to allow passage of larger balloon val· votomy catheters to the mitral anulus. The procedure resulted in a marked decrease in the diastolic transmitral Closed mitral commissurotomy is a reliable surgical technique for the treatment of patients with symptomatic mitral stenosis (1-5). This report describes the successful use of percutaneous transvenous balloon mitral valvotomy in a patient with refractory congestive heart failure due to calcific mitral stenosis.
Case Report
A 57 year old white man was admitted to the hospital with refractory congestive heart failure. He had had acute rheumatic fever as a child and developed dyspnea on exertion in 1978. In 1979, he was admitted with increasing shortness of breath. Cardiac catheterization demonstrated aortic valve stenosis and coronary artery disease involving the left anterior descending coronary artery. He underwent uneventful aortic valve replacement with a Hancock porcine bioprosthesis and a bypass graft to the diseased artery. He remained free of cardiac symptoms until 1983 when he again developed shortness of breath and was treated with digoxin gradient from 20 to 4 mm Hg. This decrease was asso· ciated with an increase in cardiac output from 3.4 to 5.7 liters/min. Mitral valve area increased from 0.7 to 2.5 cm 2 • Balloon valvotomy did not result in significant mi· tral regurgitation. This case indicates that further trials are warranted to evaluate percutaneous transseptal mi· tral valvotomy for the treatment of patients with mitral stenosis.
(J Am Coil CardioI1986; 7:1416-9) and diuretic therapy. In early 1985 he developed progressive and refractory congestive heart failure.
Other major medical problems included arterial hypertension and severe peripheral vascular disease resulting in right transmetatarsal amputation in 1983 and a left axillofemoral bypass in 1985. He had insulin-dependent diabetes mellitus for many years. with chronic renal failure due to diabetic nephropathy. He was a heavy smoker until 1970 and had severe chronic obstructive pulmonary disease.
Clinical features. Physical examination showed a critically ill man in moderate respiratory distress. The blood pressure was 140170 mm Hg and the pulse was irregular at 80/min as a result of atrial fibrillation; respirations were 28/min. The carotid pulses were normal and there were no bruits. The venous pressure was increased to 12 em above the sternal angle with prominent V waves. There were decreased breath sounds at both lung bases and bibasilar rales. Cardiac examination revealed a prominent right ventricular impulse. The first sound was variable but increased; the second sound was narrowly split with a loud pulmonary component. There was a grade 1 to 2/6 systolic murmur at the left sternal border that increased during inspiration and a grade 1 to 2/6 diastolic rumble at the apex. Examination of the abdomen was normal. There was no peripheral edema.
The electrocardiogram showed atrial fibrillation, occasional premature ventricular complexes and nonspecific ST and T wave abnormalities. The chest X-ray film showed cardiomegaly, pulmonary edema and bilateral pleural ef-fusion. Cardiac fluoroscopy demonstrated calcification of the mitral valve. A gated cardiac blood pool scan showed a left ventricular ejection fraction of 50%.
Two-dimensional echocardiographic findings were consistent with severe mitral stenosis with calcification of the septal mitral leaflet. There was evidence of left atrial enlargement, normal left ventricular size and well preserved left ventricular function. There was hypertrophy of the interventricular septum, right atrial enlargement and right ventricular hypertrophy. There was no evidence of mitral regurgitation.
The clinical course was one of refractory pulmonary edema despite aggressive medical therapy. Cardiac surgery was not an option because of the patient's other major medical problems. When all other major medical options had been exhausted, consent was obtained from the patient and from the Human Studies Committee to attempt a percutaneous mitral balloon valvotomy.
Cardiac catheterization. After elective endotracheal intubation, right heart catheterization from the right internal jugular vein and transseptal left heart catheterization from the right common femoral vein using an 8 French-Mullins transseptal long sheath and dilator (USCI) and a modified Brockenbrough needle were performed. Correct needle position in the left atrium was confirmed by oximetry and pressure measurement. The needle and dilator were removed, leaving the long sheath in the left atrium. Systemic anticoagulation was achieved by giving 100 U/kg of heparin. A 7F balloon wedge catheter was advanced through the sheath into the left atrium. The catheter was then passed into the left ventricle with the help of a 0.035 inch (0.089 cm) guide wire. Left heart pressures and the mitral transvalvular gradient were measured.
The results of cardiac catheterization are shown in Table   1 . Figure lA shows diastolic gradient across the mitral valve. Cardiac output was 3.4 liters/min and the mitral valve area was calculated at 0.7 cm 2 . There was evidence of pUlmonary hypertension with pulmonary artery pressure of 70/40 mm Hg (mean 50). The pulmonary arteriolar resistance index was elevated to 320 dynes.s.cm - 5. Mitral balloon valvotomy. The 7F flow-directed balloon catheter was advanced from the left ventricle through the aortic valve prosthesis to the ascending and then the descending aorta. A 0.038 inch (0.097 cm), 260 cm long Teflon-coated exchange wire was then passed through the catheter. The sheath and balloon catheter were then removed leaving the guide wire behind. Balloon-tipped catheters (Mansfield) for percutaneous valvotomy were used. An 8F valvotomy catheter with an 8 mm balloon was passed over the guide wire to the level of the mitral valve and the mitral valve dilated by inflating the balloon (Fig. 2A ). The balloon catheter was then pulled back until it traversed the interatrial septum and the interatrial septum was dilated by inflating the balloon twice (Fig. 2B) . Dilation of the interatrial septum allowed the passage of larger valvotomy balloon catheters (18,20 and 25 mm) which were then advanced through the left atrium and positioned across the mitral valve. The 18 mm and thereafter the 20 and 25 mm balloons were inflated to a pressure of 3 to 4 atm until the indentation in the balloon due to the mitral valve stenosis disappeared (Fig. 2C,D) . Inflation-deflation time was approximately 20 seconds. Multiple dilations were used to be sure that the balloon was in the correct position across the mitral valve.
Immediately after catheter valvotomy, all hemodynamic measurements were repeated (Table I ). Figure IB Mean pulmonary artery pressure decreased to 40 mm Hg. Right heart oximetry demonstrated no evidence of a left to right shunt across the atrial septum. Because of the presence of renal failure, left cineventriculography was not performed. However, mitral regurgitation was excluded by physical examination and by Doppler examination of the mitral valve. The procedure was completed in 2 hours and the patient tolerated it well with minimal discomfort. After mitral balloon valvotomy, the patient could be weaned from the respirator. He was transferred from the intensive care unit to a ward bed in 48 hours and later to a rehabilitation hospital and home.
Discussion
Patients with severe mitral stenosis require surgical relief of mitral obstruction by either mitral valve replacement or mitral commissurotomy. Closed commissurotomy remains a reliable surgical technique for treatment of patients with pure mitral stenosis and results in long-term hemodynamic and clinical improvement (1-5). The technique described in this report makes it possible to perform closed mitral valvotomy percutaneously. Recently, this technique was performed successfully in children and adolescents with pure noncalcific mitral stenosis (6) . Balloon mitral valvotomy was also reported (7) in adults with noncalcific mitral stenosis but the balloon catheter was introduced surgically. Similar results were described and significant mitral regurgitation seldom occurred.
Although patients with a pliable valve without calcification are ideally suited to treatment by balloon valvotomy, our report indicates that the presence of a calcified valve is not an absolute contraindication to the procedure. This procedure may be preferred or may represent the only alternative for patients who, like our patient, have incapacitating symptoms due to a stenotic, calcified mitral valve and cannot undergo cardiac surgery. Thoracotomy is avoided. The potential advantages of this technique over conventional surgical commissurotomy include the possibility of decreasing morbidity, shortening hospital stay and reducing costs. Although the long-term benefits of this procedure are unknown, they may not be different from those of surgical closed mitral commissurotomy.
Implications. Mitral commissurotomy is a palliative procedure for treating patients with mitral stenosis. Regardless of the technique of mitral commissurotomy employed, restenosis can occur (1-5). In such instances, a patient initially treated with mitral valvotomy could undergo a repeat procedure or mitral valve surgery without the difficulties resulting from previous pericardiotomy and chest wall scarring. The favorable results in this patient with cal-cific mitral stenosis indicate that further trials are warranted to evaluate percutaneous trans septal mitral valvotomy for the treatment of patients with rheumatic mitral stenosis. If the effectiveness and safety of this technique are established, it may have particular importance for those countries in which rheumatic heart disease is common.
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